Synthesis and biological evaluation of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives as potential antitumor agents. 2011

Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
ZJU-ENS Joint Laboratory of Medicinal Chemistry, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

A series of new 4β-anilino-4'-O-demethyl-4-desoxypodophyllotoxin derivatives were prepared and evaluated for their cytotoxicities against four human cancer cell lines including KB, KB/VCR, A549 and 95D. Most compounds showed better growth-inhibition activities against tested cell lines than that of etoposide (VP-16). Preliminary structure-activity relationships (SARs) were concluded and it indicated that the side chains substituted at 4β position of podophyllotoxin significantly influenced the cytotoxic activity, especially for the drug resistance profile. In vivo studies of compound 26c on highly metastatic human lung cancer xenograft in nude mice showed that it can significantly inhibit tumor growth with administrating by oral route.

UI MeSH Term Description Entries
D011034 Podophyllotoxin A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Epipodophyllotoxin,CPH86,Condyline,Condylox,Podocon-25,Podofilm,Podofilox,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer,Wartec,Warticon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
June 1993, Journal of medicinal chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
March 2005, Organic & biomolecular chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
February 1993, Pharmaceutical research,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
March 2011, European journal of medicinal chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
July 2012, Bioorganic & medicinal chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
October 2004, Journal of medicinal chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
February 2017, Bioorganic & medicinal chemistry letters,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
September 2011, European journal of medicinal chemistry,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
January 2018, Bioorganic & medicinal chemistry letters,
Li Wang, and Fenyan Yang, and Xiaochun Yang, and Xianghong Guan, and Chunqi Hu, and Tao Liu, and Qiaojun He, and Bo Yang, and Yongzhou Hu
September 2023, European journal of medicinal chemistry,
Copied contents to your clipboard!